{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:06:26Z","timestamp":1788545186829,"version":"build-2803163510"},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/100001595","name":"Dystonia Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001595","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH Intramural Program"},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1111\/ane.12701","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T09:10:53Z","timestamp":1478164253000},"page":"103-108","source":"Crossref","is-referenced-by-count":12,"title":["Lack of efficacy of levetiracetam in oromandibular and cranial dystonia"],"prefix":"10.1155","volume":"136","author":[{"given":"J. E.","family":"Park","sequence":"first","affiliation":[{"name":"Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA"},{"name":"Department of Neurology; Dongguk University Ilsan Hospital; Goyang Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Srivanitchapoom","sequence":"additional","affiliation":[{"name":"Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA"},{"name":"Division of Neurology; Department of Medicine; Siriraj Hospital; Mahidol University; Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. W.","family":"Maurer","sequence":"additional","affiliation":[{"name":"Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mathew","sequence":"additional","affiliation":[{"name":"Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sackett","sequence":"additional","affiliation":[{"name":"Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Paine","sequence":"additional","affiliation":[{"name":"Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA"},{"name":"Food and Drug Administration (FDA) Center for Devices and Radiologic Health; Office of Device Evaluation; Division of Neurological and Physical Medicine; Neurodiagnostics and Neurosurgical Devices Branch; White Oak MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. L.","family":"Ramos","sequence":"additional","affiliation":[{"name":"Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA"},{"name":"Food and Drug Administration (FDA) Center for Devices and Radiologic Health; Office of Device Evaluation; Division of Neurological and Physical Medicine; Neurodiagnostics and Neurosurgical Devices Branch; White Oak MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hallett","sequence":"additional","affiliation":[{"name":"Human Motor Control Section; National Institute of Neurological Disorders and Stroke; National Institutes of Health; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"10.1111\/ane.12701-BIB0001|ane12701-cit-0001","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/mds.870030302","article-title":"Epidemiology of focal and generalized dystonia in Rochester, Minnesota","volume":"3","author":"Nutt","year":"1988","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12701-BIB0002|ane12701-cit-0002","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/WNL.53.9.2102","article-title":"Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up","volume":"53","author":"Tan","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/ane.12701-BIB0003|ane12701-cit-0003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/mds.870030107","article-title":"Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs","volume":"3","author":"Greene","year":"1988","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12701-BIB0004|ane12701-cit-0004","first-page":"443","article-title":"Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome)","volume":"49","author":"Klawans","year":"1988","journal-title":"Adv Neurol"},{"key":"10.1111\/ane.12701-BIB0005|ane12701-cit-0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/WNL.38.3.391","article-title":"Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias","volume":"38","author":"Jankovic","year":"1988","journal-title":"Neurology"},{"key":"10.1111\/ane.12701-BIB0006|ane12701-cit-0006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0404.2006.00624.x","article-title":"Levetiracetam in Meige's syndrome","volume":"114","author":"Yardimci","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12701-BIB0007|ane12701-cit-0007","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/mds.20233","article-title":"Substantial improvement in a Meige's syndrome patient with levetiracetam treatment","volume":"19","author":"Zesiewicz","year":"2004","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12701-BIB0008|ane12701-cit-0008","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/ane.12701-BIB0009|ane12701-cit-0009","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.parkreldis.2005.05.001","article-title":"Levetiracetam for the treatment of generalized dystonia","volume":"11","author":"Sullivan","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/ane.12701-BIB0010|ane12701-cit-0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tripleo.2003.08.011","article-title":"Treatment of perioral dystonia with botulinum toxin in 4 cases of Meige's syndrome","volume":"96","author":"Moller","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/ane.12701-BIB0011|ane12701-cit-0011","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/mds.20873","article-title":"An open-label trial of levetiracetam for treatment of cervical dystonia","volume":"21","author":"Tarsy","year":"2006","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12701-BIB0012|ane12701-cit-0012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.parkreldis.2010.11.013","article-title":"Bilateral pallidal deep brain stimulation in primary Meige syndrome","volume":"17","author":"Sako","year":"2011","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12701","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12701","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12701\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:50:02Z","timestamp":1671540602000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12701","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,3]]}}}